UGT1A1 and colorectal carcinoma: Variations in ACE, UCP2, TYMS, IL4, NFKB1, CASP8, TP53, HLAG, UGT1A1, and SGSM3 were linked to CRC risk and clinical characteristics, suggesting that this genetic marker panel could enhance clinical management.